# Synexus Clinical Research US, Inc. – FDA Inspection, May 11, 2017

Source: https://www.keypedia.com/records/fda_inspections/synexus-clinical-research-us-inc/8e120362-1646-427b-b6d4-19ce12823d60
Source feed: FDA_Inspections

> FDA inspection 1015462 of Synexus Clinical Research US, Inc., May 11, 2017. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1015462
- Company Name: Synexus Clinical Research US, Inc.
- Inspection Date: 2017-05-11
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Dallas District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1029957 - 2017-08-04

## Related Officers

- [Company Rep](https://www.keypedia.com/people/camille-d-brown/419869d2-1810-40ea-8e8a-687de7013f6a)

Company: https://www.keypedia.com/companies/synexus-clinical-research-us-inc/401e42fc-af99-4c1f-b8df-b86b7526900a

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9